Delivery Order SPE2DX22D0010-SPE2D826FCP83
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Percocet Tablets 10/325 mg with a contract ceiling value of $16,862.51. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by January 23, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $40,640.81. This firm fixed-price delivery order, with an ultimate completion date of October 21, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $24,245.78 for Percocet tablets (10/325 mg) on December 22, 2025, with completion targeted for December 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and represents a child award under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Percocet Tablets (10/325 mg) with a ceiling value of $23,778.44. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 29,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $17,828.87 to AmerisourceBergen Drug Corp for Percocet tablets (10/325 mg) on August 25, 2025, with completion by August 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 13, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $13,210.51. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Percocet tablets (10/325 mg) valued at $9,710.48. This firm fixed-price, non-set-aside delivery order is scheduled for completion by November 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Percocet tablets (10/325 mg) with a ceiling value of $20,054.90. This firm fixed-price delivery order, which must be completed by August 28, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a competitive delivery order valued at $13,613.85 on January 20, 2026, by the Defense Logistics Agency's Medical Supply Chain to supply Percocet tablets (10/325 mg). This firm fixed-price delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. The award was made on a full and open competitive basis with no set-aside designation. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Percocet Tabs 10/325 mg with a ceiling value of $36,165.79. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract requires completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCP83Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Percocet tablets (10/325 mg) with a contract value of $18,171.08. This firm fixed-price delivery order is non-competitive and represents a task order under a larger Indefinite Delivery Contract vehicle. The order is scheduled for completion by January 22, 2026, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, including military treatment facilities and veteran healthcare programs. This delivery order leverages AmerisourceBergen's prime Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare operations. The Percocet supply falls within the company's broader portfolio of pain management pharmaceuticals delivered through this comprehensive pharmaceutical prime vendor agreement. As a non-set-aside award, this order reflects AmerisourceBergen's competitive capability to meet federal medical procurement requirements for controlled pharmaceutical substances required by the Defense Health Agency and other military healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 1/20/26 |